These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 20839059)

  • 1. Effects of intraperitoneal chemotherapy with mitomycin C on the prevention of peritoneal recurrence in colorectal cancer patients with positive peritoneal lavage cytology findings.
    Noura S; Ohue M; Shingai T; Kano S; Ohigashi H; Yano M; Ishikawa O; Takenaka A; Murata K; Kameyama M
    Ann Surg Oncol; 2011 Feb; 18(2):396-404. PubMed ID: 20839059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
    Chua TC; Morris DL; Esquivel J
    Ann Surg Oncol; 2010 May; 17(5):1330-6. PubMed ID: 20033321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and long-term outcome.
    Brouquet A; Goéré D; Lefèvre JH; Bonnet S; Dumont F; Raynard B; Elias D
    Ann Surg Oncol; 2009 Oct; 16(10):2744-51. PubMed ID: 19626375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
    Bijelic L; Yan TD; Sugarbaker PH
    Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prognostic value of positive peritoneal lavage cytology and the prevention of peritoneal dissemination after colorectal surgery].
    Tanida T; Noura S; Ohue M; Seki Y; Gotoh K; Motoori M; Kishi K; Takachi K; Yamada T; Miyashiro I; Ohigashi H; Yano M; Ishikawa O; Imaoka S; Murata K; Kameyama M
    Gan To Kagaku Ryoho; 2007 Nov; 34(12):1937-9. PubMed ID: 18219858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
    Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
    Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New treatment of peritoneal carcinomatosis from colorectal cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
    Iversen LH; Rasmussen PC; Laurberg S
    Ugeskr Laeger; 2007 Sep; 169(38):3179-81. PubMed ID: 17910824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center.
    Carpizo DR; Are C; Jarnagin W; Dematteo R; Fong Y; Gönen M; Blumgart L; D'Angelica M
    Ann Surg Oncol; 2009 Aug; 16(8):2138-46. PubMed ID: 19495884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperthermic intra-peritoneal chemotherapy (HIPEC) in patients with peritoneal pseudomyxoma or peritoneal metastases of colorectal carcinoma; good preliminary results from the Netherlands Cancer Institute].
    Zoetmulder FA; van der Vange N; Witkamp AJ; Kaag MM; Boot H; Beijnen JH
    Ned Tijdschr Geneeskd; 1999 Sep; 143(37):1863-8. PubMed ID: 10526600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival of peritoneal carcinomatosis of colorectal origin.
    Verwaal VJ; van Ruth S; Witkamp A; Boot H; van Slooten G; Zoetmulder FA
    Ann Surg Oncol; 2005 Jan; 12(1):65-71. PubMed ID: 15827780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal cytology in colorectal cancer: incidence and prognostic value.
    Gozalan U; Yasti AC; Yuksek YN; Reis E; Kama NA
    Am J Surg; 2007 Jun; 193(6):672-5. PubMed ID: 17512274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Specific treatment situations in metastatic colorectal cancer].
    Arnold D; Schmoll HJ; Lang H; Knoefel WT; Ridwelski K; Trarbach T; Staib L; Kirchner T; Geissler M; Seufferlein T; Amthauer H; Riess H; Schlitt HJ; Piso P
    Onkologie; 2010; 33 Suppl 4():8-18. PubMed ID: 20431307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of CEA levels and positive cytology in peritoneal washings in patients with colorectal cancer.
    Kanellos I; Zacharakis E; Kanellos D; Pramateftakis MG; Betsis D
    Colorectal Dis; 2006 Jun; 8(5):436-40. PubMed ID: 16684089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxaliplatin versus Mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis.
    Leung V; Huo YR; Liauw W; Morris DL
    Eur J Surg Oncol; 2017 Jan; 43(1):144-149. PubMed ID: 27780675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.
    da Silva RG; Sugarbaker PH
    J Am Coll Surg; 2006 Dec; 203(6):878-86. PubMed ID: 17116556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis.
    Van der Speeten K; Stuart OA; Chang D; Mahteme H; Sugarbaker PH
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):147-56. PubMed ID: 20857115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer.
    Carmignani CP; Ortega-Perez G; Sugarbaker PH
    Eur J Surg Oncol; 2004 May; 30(4):391-8. PubMed ID: 15063892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal cytology in colorectal cancer: incidence and prognostic value.
    Rekhraj S; Aziz O; Zacharakis E; Ziprin P
    Am J Surg; 2008 Oct; 196(4):617-8. PubMed ID: 18809068
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
    Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
    Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis.
    Elias D; Benizri E; Di Pietrantonio D; Menegon P; Malka D; Raynard B
    Ann Surg Oncol; 2007 Feb; 14(2):509-14. PubMed ID: 17096054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.